Table Of Content

Clinica Chimica Acta 264 (1997) 261-263 Author index Volume 264 (1997) Abraham-Inpijn, L., see Brand, H.S. 264, 37 Erginel, S., see Metintas, M. 264, 149 Adam, A., see Sgrensen, S.H. 264, 103 Estelberger, W., see Reibnegger, G. 264, 207 Alatas, F., see Metintas, M. 264, 149 Alatas, O., see Metintas, M. 264, 149 Férard, G., see Bourguignat, A. 264, 27 Aubé, C., see Senti, M. 264, 193 Fingerhut, R., Stehn, M., Kohlschiitter, A., Com- Aung, W., Kyaw, A., Win, T., Kyaw, K.-P.-P., Hla, parison of four different phenylalanine determi- B., Hlaing, T.-T., Isoenzyme profile of urinary nation methods 264, 65 NAG in Russell’s viper bite patients with renal Finotti, P., Pagetta, A., Albumin contamination of a damage 264, 251 purified human a,-antitrypsin preparation does not affect either structural conformation or the Bahadir, S., see Orem, A. 264, 49 electrophoretic mobility of the inhibitor 264, Batt, R.M., see Sgrensen, S.H. 264, 103 133 Bergeron, C., see Mathieu, P. 264, 255 Frappaz, D., see Mathieu, P. 264, 255 Bernard, H., see Taran, F. 264, 177 Fujita, K., Immunochemical study of immuno- Bory, C., see Mathieu, P. 264, 255 globulins bound to lactate dehydrogenase 264, Bourguignat, A., Férard, G., Jenny, J.-Y., Gaudias, 163 J., Incomplete or absent acute phase response in some postoperative patients 264, 27 Gaudias, J., see Bourguignat, A. 264, 27 Brand, H.S., Jodrning, G.G.A., Chamuleau, Gonczdl, E., see Valyi-Nagy, I. 264, 117 R.A.F.M., Abraham-Inpijn, L., Effect of a Gotto Jr., A.M., see Lambert, D.A. 264, 75 protein-rich meal on urinary and salivary free Grassi, J., see Taran, F. 264, 177 amino acid concentrations in human Greffe, J., see Mathieu, P. 264, 255 subjects 264, 37 Gunter, E.W., see Spierto, FW. 264, 227 Brown, J.H., see McGrath, L.T. 264, 1 Habbal, Z.M., Sakr, A., Rapid, specific HPLC Catapano, A.L., see Lambert, D.A. 264, 75 method for the determination of argininosuccinic Chamuleau, R.A.F.M., see Brand, H.S. 264, 37 acid following pre-column derivatization with Chauvin, F., see Mathieu, P. 264, 255 o-phthaladehyde 264, 239 Cimsit, G., see Orem, A. 264, 49 Hannon, W.H., see Spierto, FW. 264, 227 Colak, O., see Metintas, M. 264, 149 Hla, B., see Aung, W. 264, 251 Créminon, C., see Taran, F. 264, 177 Hlaing, T.-T., see Aung, W. 264, 251 Huang, X.-H., Koivula, T., Ilveskoski, E., Kar- David, L., see Mathieu, P. 264, 255 hunen, P.J., Rantalaiho,V. ,W irta, O., Pasternack, Deger, O., see Orem, A. 264, 49 A., Lehtimaki, T., Fast 5-hour determination of Deverre, J.-R., see Taran, F. 264, 177 angiotensin-converting enzyme genotypes from Dia, S., see Mathieu, P. 264, 255 blood by SDS-PAGE using PhastSystem 264, Domjan, G., see Valyi-Nagy, I. 264, 117 57 0009-8981/97/$17.00 Elsevier Science BV. All rights reserved PIT $0009-8981(97)00126-5 262 Author index vol. 264 (1997) Ilveskoski, E., see Huang, X.-H. 264, 57 Ozdemir, N., Erginel, S., Comparative analysis Isobe, K., see Nomura, F. 264, 233 of biochemical parameters for differentiation of Itoga, S., see Nomura, F. 264, 233 pleural exudates from _ transudates Light’s Iwasa, S., see Iwata, S. 264, 245 criteria, cholesterol, bilirubin, albumin gradient, Iwata, S., Sukegawa, K., Sasaki, T., Kokuryu, M., alkaline phosphatase, creatine kinase, and uric Yamasita, S., Noma, A., Iwasa, S., Kondo, N., acid 264, 149 Orii, T., Mass screening test for mucopolysac- charidoses using the 1,9-dimethylmethylene blue Nagasawa, K., see Yoshizawa, S. 264, 219 method. Positive interference from paper Nakai, T., see Nomura, F. 264, 233 diapers 264, 245 Niho, Y., see Yoshizawa, S. 264, 219 Noda, M., see Nomura, F. 264, 233 Jak6, J.M., see Valyi-Nagy, I. 264, 117 Noma, A., see Iwata, S. 264, 245 Jenny, J.-Y., see Bourguignat, A. 264, 27 Nomura, F., Takashima, H., Itoga, S., Isobe, K., Jian Hua, M., Yong Kun, H., Shi Jie, C., Zhi Yun, Takekoshi, K., Noda, M., Nakai, T., Serum NAD N., Qing De, W., Yang, Z., Urinary microalbumin glycohydrolase activities in normal subjects and and retinol-binding protein assay for verifying in patients with chronic liver diseases 264, 233 children’s nephron development and maturation 264, 127 Okochi, K., see Yoshizawa, S. 264, 219 Jérning, G.G.A., see Brand, H.S. 264, 37 Olichon, D., see Taran, F. 264, 177 Orem, A., Deger, O., Cimsit, G., Bahadir, S., Kaffka, K.J., see Valyi-Nagy, I. 264, 117 Plasma polymorphonuclear leukocyte elastase Karhunen, P.J., see Huang, X.-H. 264, 57 levels and its relation to disease activity in Kohlschiitter, A., see Fingerhut, R. 264, 65 psoriasis 264, 49 Koivula, T., see Huang, X.-H. 264, 57 Orii, T., see Iwata, S. 264, 245 Kokuryu, M., see Iwata, S. 264, 245 Ozdemir, N., see Metintas, M. 264, 149 Kondo, N., see Iwata, S. 264, 245 Kyaw, A., see Aung, W. 264, 251 Pagetta, A., see Finotti, P. 264, 133 Kyaw, K.-P.-P., see Aung, W. 264, 251 Pasternack, A., see Huang, X.-H. 264, 57 Pavesi, M., see Senti, M. 264, 193 Lambert, D.A., Catapano, A.L., Smith, L.C., Spar- Pedro-Botet, J., see Senti, M. 264, 193 row, J.T., Gotto Jr., A.M., A new fluorometric Pena, A., see Senti, M. 264, 193 method for measuring the action of C apolipo- Petrov, V., see Lijnen, P. 264, 91 proteins on milk lipoprotein lipase 264, 75 Philip, T., see Mathieu, P. 264, 255 Lang, T., see Reibnegger, G. 264, 207 Pradelles, P., see Taran, F. 264, 177 Lehtimaki, T., see Huang, X.-H. 264, 57 Prevel, A., see Mathieu, P. 264, 255 Lijnen, P., Saavedra, A., PetrovV,. , In vitro prolifer- Proud, F.J., see Sgrensen, S.H. 264, 103 ative response of human peripheral blood mononuclear cells to concanavalin A 264, 91 Qing De, W., see Jian Hua, M. 264, 127 Markwell, P., see Sgrensen, S.H. 264, 103 Raghothama, C., Rao, P., Degradation of glycated Marrugat, J., see Senti, M. 264, 193 hemoglobin. Role of erythrocytic proteolytic Martin, S., see Senti, M. 264, 193 enzymes and oxidant damage 264, 13 Mathieu, M., see Mathieu, P. 264, 255 Rantalaiho, V., see Huang, X.-H. 264, 57 Mathieu, P., Prevel, A., David, L., Bergeron, C., Rao, P., see Raghothama, C. 264, 13 Bory, C., Chauvin, F., Dia, S., Frappaz, D., Reibnegger, G., Lang, T., Estelberger, W., Infor- Greffe, J., Mathieu, M., Philip, T., Screening mation theoretical concepts in clinical chemistry: infants for neuroblastoma: discovery of alkap- the use of spreadsheet programs for convenient tonuria in one case 264, 255 calculation of information theoretical McClean, E., see McGrath, L.T. 264, 1 quantities 264, 207 McGrath, L.T., Treacy, R., McClean, E., Brown, Rubiés-Prat, J., see Senti, M. 264, 193 J.H., Oxidative stress in cyclosporin §a nd Rutgers, H.C., see Sgrensen, S.H. 264, 103 azathioprine treated renal transplant patients 264, | Saavedra, A., see Lijnen, P. 264, 91 Metintas, M., Alatas, O., Alatas, F., Colak, O., Sakr, A., see Habbal, Z.M. 264, 239 Author index vol. 264 (1997) 263 Sasaki, T., see Iwata, S. 264, 245 Treacy, R., see McGrath, L.T. 264, 1 Senti, M., Pedro-Botet, J., Pavesi, M., Marrugat, J., Aubo, C., Pena, A., Martin, S., Rubiés-Prat, J., Valleix, A., see Taran, F. 264, 177 Interaction of family history of atherosclerosis Valyi-Nagy, I., Kaffka, K.J., Jak6, J.M., G6énczol, with atherogenic lipid traits in men with non- E., Domjan, G., Application of near infrared coronary atherosclerosis 264, 193 spectroscopy to the determination of Shi Jie, C., see Jian Hua, M. 264, 127 haemoglobin 264, 117 Smith, L.C., see Lambert, D.A. 264, 75 Smith, S.J., see Spierto, FW. 264, 227 Win, T., see Aung, W. 264, 251 Sgrensen, S.H., Proud, F.J., Rutgers, H.C., Mark- Wirta, O., see Huang, X.-H. 264, 57 well, P., Adam, A., Batt, R.M., A blood test for intestinal permeability and function: A new tool Yae, Y., see Yoshizawa, S. 264, 219 for the diagnosis of chronic intestinal disease in Yamasita, S., see Iwata, S. 264, 245 dogs 264, 103 Yang, Z., see Jian Hua, M. 264, 127 Sparrow, J.T., see Lambert, D.A. 264, 75 Yong Kun, H., see Jian Hua, M. 264, 127 Spierto, F.W., Hannon, W.H., Gunter, E.W., Smith, Yoshizawa, S., Nagasawa, K., Yae, Y., Niho, Y., S.J., Stability of urine creatinine 264, 227 Okochi, K., A thermolabile 62-macroglycopro- Stehn, M., see Fingerhut, R. 264, 65 tein (TMG) and the antibody against TMG in Sukegawa, K., see Iwata, S. 264, 245 patients with systemic lupus _ erythematosus 264, 219 Takashima, H., see Nomura, F. 264, 233 Takekoshi, K., see Nomura, F. 264, 233 Zhi Yun, N., see Jian Hua, M. 264, 127 Taran, F., Bernard, H., Valleix, A., Créminon, C., Grassi, J., Olichon, D., Deverre, J.-R., Pradelles, P., Competitive enzyme immunoassay for urinary vanillylmandelic acid 264, 177 Clinica Chimica Acta 264 (1997) 265-268 Subject index Volume 264 (1997) Acute phase response; C-reactive protein; Trans- assay; Vanillylmandelic acid; Homovanillic acid; thyretin; Open fracture 264, 27 Neuroblastoma; Pheochromocytoma 264, 177 Alkaptonuria; Neuroblastoma (NB); Vanillylman- Complex formation; LD-BJP complex; LD-IgG delic acid (VMA); Homovanillic acid (HVA); complex; NAD” binding site; Tyrosine; B-sheet Homogentisic acid 264, 255 structure 264, 163 Angiotensin-converting enzyme; Electrophoresis; Computer programs; Test evaluation; Entropy; Genetic polymorphism; Polymerase chain re- Uncertainty; Information content; Transinforma- action 264, 57 tion 264, 207 q@,-Antitrypsin; Serum albumin; Purification; Concanavalin A; Proliferation; Mononuclear cells Structural conformation; (Human) 264, 133 264, 91 Apolipoproteins; Lipoprotein lipase; Protein cofac- Creatinine; Stability; Urine; Temperature; Time tors 264, 75 264, 227 Argininosuccinic acid; O-phthaladehyde; Urea Cyclosporin; Oxidative stress; Renal transplanta- 264, 239 tion; Azathioprine; Free radicals 264, 1 Atherosclerosis; lipoproteins; lipoprotein (a); LDL Development; RBP; MALB; Nephron; Maturation subclasses 264, 193 264, 127 Autoantibody; $2-macroglycoprotein; Systemic Diabetes mellitus; Glycated hemoglobin; Oxidant lupus erythematosus (SLE) 264, 219 damaged hemoglobin; Erythrocytes; Proteolytic enzymes 264, 13 Azathioprine; Oxidative stress; Renal transplantation; Cyclosporin; Free radicals 264, 1 1,9-Dimethylmethylene blue; Mucopolysac- charidosis; Mass screening; Glycosaminoglycans Blood; Rhamnose; 3-O-methyl-p-glucose; Xylose; 264, 245 Lactulose; HPLC; Glucose elimination 264, 103 Electrophoresis; Angiotensin-converting enzyme; C-reactive protein; Transthyretin; Acute phase Genetic polymorphism; Polymerase chain re- response; Open fracture 264, 27 action 264, 57 Catecholamine metabolites; Enzyme immuno- Entropy; Test evaluation; Uncertainty; Information 0009-8981/97/$17.00 Elsevier Science BV. All rights reserved PIT $0009-8981(97)00127-7 266 Subject index vol. 264 (1997) content; Transinformation; Computer programs Information content; Test evaluation; Entropy; 264, 207 Uncertainty; Transinformation; Computer programs 264, 207 Enzyme immunoassay; Vanillylmandelic acid; Homovanillic acid; Catecholamine metabolites; Isoenzymes; Urinary NAG; Viper; Renal damage Neuroblastoma; Pheochromocytoma 264, 177 264, 251 Erythrocytes; Glycated hemoglobin; Oxidant dam- LDL subclasses; Atherosclerosis; lipoproteins; aged hemoglobin; Proteolytic enzymes; Diabetes lipoprotein (a) 264, 193 mellitus 264, 13 LD-BJP complex; LD-IgG complex; NAD* Free radicals; Oxidative stress; Renal transplanta- binding site; Tyrosine; B-sheet structure; Com- tion; Cyclosporin; Azathioprine 264, 1 plex formation 264, 163 Genetic polymorphism; Angiotensin-converting LD-IgG complex; LD-BJP complex; NAD* enzyme; Electrophoresis; Polymerase chain re- binding site; Tyrosine; B-sheet structure; Com- action 264, 57 plex formation 264, 163 Glucose elimination; Rhamnose; 3-O-methyl-p- Lactulose; Rhamnose; 3-O-methyl-p-glucose; glucose; Xylose; Lactulose; HPLC; Blood 264, Xylose; HPLC; Blood; Glucose elimination 103 264, 103 Glycated hemoglobin; Oxidant damaged hemoglo- Lipoprotein lipase; Apolipoproteins; Protein bin; Erythrocytes; Proteolytic enzymes; Diabetes cofactors 264, 75 mellitus 264, 13 lipoprotein (a); Atherosclerosis; lipoproteins; LDL Glycosaminoglycans; Mucopolysaccharidosis; 1,9- subclasses 264, 193 Dimethylmethylene blue; Mass screening 264, 245 lipoproteins; Atherosclerosis; lipoprotein (a); LDL subclasses 264, 193 Haemoglobin concentration; Near infrared (NIR) spectroscopy; Reagentless determination of Liver cirrhosis; NAD glycohydrolase 264, 233 haemoglobin 264, 117 Homogentisic acid; Neuroblastoma (NB); Alkap- 2-macroglycoprotein; Autoantibody; Systemic lupus erythematosus (SLE) 264, 219 tonuria; -V anillylmandelic acid (VMA); Homovanillic acid (HVA) 264, 255 MALB; RBP; Nephron; Development; Maturation Homovanillic acid (HVA); Neuroblastoma (NB); 264, 127 Alkaptonuria; Vanillylmandelic acid (WMA); Homogentisic acid 264, 255 Mass screening; Mucopolysaccharidosis; 1,9-Di- methylmethylene blue; Glycosaminoglycans Homovanillic acid; Enzyme immunoassay; Van- 264, 245 illylmandelic acid; Catecholamine metabolites; Neuroblastoma; Pheochromocytoma 264, 177 Maturation; RBP; MALB; Nephron; Development 264, 127 HPLC; Rhamnose; 3-O-methyl-p-glucose; Xylose; Lactulose; Blood; Glucose elimination 264, 103 3-O-methyl-p-glucose; Rhamnose; Xylose; Lactu- lose; HPLC; Blood; Glucose elimination 264, (Human); Serum albumin; a@,-Antitrypsin; Purifi- 103 cation; Structural conformation 264, 133 Mononuclear cells; Concanavalin A; Proliferation Inflammation; PMN elastase; Psoriasis 264, 49 264, 91 Subject index vol. 264 (1997) 267 Mucopolysaccharidosis; _1,9-Dimethylmethylene Polymerase chain reaction; Angiotensin-convert- blue; Mass screening; Glycosaminoglycans 264, ing enzyme; Electrophoresis; Genetic polymor- 245 phism 264, 57 NAD glycohydrolase; Liver cirrhosis 264, 233 Proliferation; Concanavalin A; Mononuclear cells 264, 91 NAD* binding site; LD-BJP complex; LD-IgG complex; Tyrosine; B-sheet structure; Complex Protein cofactors; Apolipoproteins; Lipoprotein formation 264, 163 lipase 264, 75 Near infrared (NIR) spectroscopy; Haemoglobin Proteolytic enzymes; Glycated hemoglobin; Oxid- concentration; Reagentless determination of ant damaged hemoglobin; Erythrocytes; Diabetes haemoglobin 264, 117 mellitus 264, 13 Nephron; RBP; MALB; Development; Maturation Psoriasis; PMN elastase; Inflammation 264, 49 264, 127 Purification; Serum albumin; a,-Antitrypsin; Neuroblastoma; Enzyme immunoassay; Van- Structural conformation; (Human) 264, 133 illylmandelic acid; Homovanillic acid; Catechol- amine metabolites; Pheochromocytoma 264, RBP; MALB; Nephron; Development; Maturation 177 264, 127 Neuroblastoma (NB); Alkaptonuria; Vanillylman- Reagentless determination of haemoglobin; Near delic acid (VMA); Homovanillic acid (HVA); infrared (NIR) spectroscopy; Haemoglobin con- Homogentisic acid 264, 255 centration 264, 117 New-born screening; Phenylketonuria 264, 65 Renal damage; Urinary NAG; Isoenzymes; Viper 264, 251 O-phthaladehyde; Argininosuccinic acid; Urea 264, 239 Renal transplantation; Oxidative stress; Cyclo- sporin; Azathioprine; Free radicals 264, 1 Open fracture; C-reactive protein; Transthyretin; Acute phase response 264, 27 Rhamnose; 3-O-methyl-p-glucose; Xylose; Lactu- lose; HPLC; Blood; Glucose elimination 264, Oxidant damaged hemoglobin; Glycated hemo- 103 globin; Erythrocytes; Proteolytic enzymes; Dia- betes mellitus 264, 13 Saliva; Plasma; Threonine; Urine; Valine 264, 37 Oxidative stress; Renal transplantation; Cyclo- Serum albumin; a,-Antitrypsin; Purification; sporin; Azathioprine; Free radicals 264, 1 Structural conformation; (Human) 264, 133 PMN elastase; Inflammation; Psoriasis 264, 49 Serum cholesterol; Pleural fluid; Uric acid 264, 149 Phenylketonuria; New-born screening 264, 65 f-sheet structure; LD-BJP complex; LD-IgG Pheochromocytoma; Enzyme immunoassay; Van- complex; NAD* binding site; Tyrosine; Com- illylmandelic acid; Homovanillic acid; Catechol- plex formation 264, 163 amine metabolites; Neuroblastoma 264, 177 Stability; Creatinine; Urine; Temperature; Time Plasma; Saliva; Threonine; Urine; Valine 264, 37 264, 227 Pleural fluid; Uric acid; Serum cholesterol 264, Structural conformation; Serum albumin; a@,-An- 149 titrypsin; Purification; (Human) 264, 133 268 Subject index vol. 264 (1997) Systemic lupus erythematosus (SLE); Autoanti- Uric acid; Pleural fluid; Serum cholesterol 264, body; 82-macroglycoprotein 264, 219 149 Temperature; Creatinine; Stability; Urine; Time Uric acid; Pleural fluid; Uric acid; Serumcholes- 264, 227 terol 264, 149 Test evaluation; Entropy; Uncertainty; Information Urinary NAG; Isoenzymes; Viper; Renal damage content; Transinformation; Computer programs 264, 251 264, 207 Urine; Creatinine; Stability; Temperature; Time Threonine; Plasma; Saliva; Urine; Valine 264, 37 264, 227 Time; Creatinine; Stability; Urine; Temperature Urine; Plasma; Saliva; Threonine; Valine 264, 37 264, 227 Valine; Plasma; Saliva; Threonine; Urine 264, 37 Transinformation; Test evaluation; Entropy; Un- certainty; Information content; Computer pro- Vanillylmandelic acid (VMA); Neuroblastoma grams 264, 207 (NB); Alkaptonuria; Homovanillic acid (HVA); Homogentisic acid 264, 255 Transthyretin; C-reactive protein; Acute phase response; Open fracture 264, 27 Vanillylmandelic acid; Enzyme immunoassay; Homovanillic acid; Catecholamine metabolites; Tyrosine; LD-BJP complex; LD-IgG complex; Neuroblastoma; Pheochromocytoma 264, 177 NAD” binding site; B-sheet structure; Complex formation 264, 163 Viper; Urinary NAG; Isoenzymes; Renal damage 264, 251 Uncertainty; Test evaluation; Entropy; Information content; Transinformation; Computer programs Xylose; Rhamnose; 3-O-methyl-p-glucose; Lactul- 264, 207 ose; HPLC; Blood; Glucose elimination 264, 103 Urea; Argininosuccinic acid; O-phthaladehyde 264, 239